ArticleIBRO reports2019

Long-term interleukin-33 treatment delays disease onset and alleviates astrocytic activation in a transgenic mouse model of amyotrophic lateral sclerosis.

Paula Korhonen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.